Loading…
Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke
1 Cardiovascular Research Institute and Departments of Medicine and Physiology, University of California, San Francisco, California 94143-0130; and 2 Department of Pulmonary Research, Boehringer Ingelheim, 55216 Ingelheim, Germany Mucus hypersecretion from hyperplastic airway goblet cells is a hal...
Saved in:
Published in: | American journal of physiology. Lung cellular and molecular physiology 2001-01, Vol.280 (1), p.165-L172 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1 Cardiovascular Research Institute and Departments of
Medicine and Physiology, University of California, San Francisco,
California 94143-0130; and 2 Department of Pulmonary
Research, Boehringer Ingelheim, 55216 Ingelheim, Germany
Mucus
hypersecretion from hyperplastic airway goblet cells is a hallmark of
chronic obstructive pulmonary disease (COPD). Although cigarette
smoking is thought to be involved in mucus hypersecretion in COPD, the
mechanism by which cigarette smoke induces mucus overproduction is
unknown. Here we show that activation of epidermal growth factor
receptors (EGFR) is responsible for mucin production after inhalation
of cigarette smoke in airways in vitro and in vivo. In the airway
epithelial cell line NCI-H292, exposure to cigarette smoke upregulated
the EGFR mRNA expression and induced activation of
EGFR-specific tyrosine phosphorylation, resulting in upregulation of
MUC5AC mRNA and protein production, effects that were
inhibited completely by selective EGFR tyrosine kinase inhibitors
(BIBX1522, AG-1478) and that were decreased by antioxidants. In vivo,
cigarette smoke inhalation increased MUC5AC mRNA and goblet
cell production in rat airways, effects that were prevented by
pretreatment with BIBX1522. These effects may explain the goblet cell
hyperplasia that occurs in COPD and may provide a novel strategy for
therapy in airway hypersecretory diseases.
human goblet factor; airway epithelial differentiation
*
Kiyoshi Takeyama and Birgit Jung contributed equally to
this work. |
---|---|
ISSN: | 1040-0605 1522-1504 |
DOI: | 10.1152/ajplung.2001.280.1.l165 |